{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:57:02Z","timestamp":1790661422300,"version":"4.1.0"},"reference-count":20,"publisher":"Medical Journals Sweden AB","issue":"10","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Abstract is missing (Short communication)<\/jats:p>","DOI":"10.2340\/actadv.v101.545","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T13:42:41Z","timestamp":1635169361000},"page":"adv00581","source":"Crossref","is-referenced-by-count":25,"title":["Rapid Enlargement of Vitiligo Vulgaris after Initiation of Dupilumab for Atopic Dermatitis: A Case Report"],"prefix":"10.2340","volume":"101","author":[{"given":"Shintaro","family":"Takeoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikumi","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"key":"4080","doi-asserted-by":"crossref","unstructured":"Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 2016; 375: 2335-2348.","DOI":"10.1056\/NEJMoa1610020"},{"key":"4081","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMoa1610020","DOI":"10.1056\/NEJMoa1610020"},{"key":"4082","doi-asserted-by":"crossref","unstructured":"Uchida H, Kamata M, Mizukawa I, Watanabe A, Agematsu A, Nagata M, et al. Real-world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study. Br J Dermatol 2019; 181: 1083-1085.","DOI":"10.1111\/bjd.18163"},{"key":"4083","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.18163","DOI":"10.1111\/bjd.18163"},{"key":"4084","doi-asserted-by":"crossref","unstructured":"Uchida H, Kamata M, Kato A, Mizukawa I, Watanabe A, Agematsu A, et al. One-year real-world clinical effectiveness, safety, and laboratory safety of dupilumab in Japanese adult patients with atopic dermatitis: a single-center retrospective study. J Am Acad Dermatol 2021; 84: 547-550.","DOI":"10.1016\/j.jaad.2020.05.102"},{"key":"4085","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2020.05.102","DOI":"10.1016\/j.jaad.2020.05.102"},{"key":"4086","doi-asserted-by":"crossref","unstructured":"Wa\u0144kowicz-Kali\u0144ska A, van den Wijngaard RM, Tigges BJ, Westerhof W, Ogg GS, Cerundolo V, et al. Immunopolarization of CD4+ and CD8+ T cells to type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest 2003; 83: 683-695.","DOI":"10.1097\/01.LAB.0000069521.42488.1B"},{"key":"4087","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/01.LAB.0000069521.42488.1B","DOI":"10.1097\/01.LAB.0000069521.42488.1B"},{"key":"4088","doi-asserted-by":"crossref","unstructured":"Yang L, Wei Y, Sun Y, Shi W, Yang J, Zhu L, et al. Interferon-gamma inhibits melanogenesis and induces apoptosis in melanocytes: a pivotal role of CD8+ cytotoxic t lymphocytes in vitiligo. Acta Derm Venereol 2015; 95: 664-670.","DOI":"10.2340\/00015555-2080"},{"key":"4089","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2340\/00015555-2080","DOI":"10.2340\/00015555-2080"},{"key":"4090","doi-asserted-by":"crossref","unstructured":"Cheuk S, Schlums H, Gallais S\u00e9r\u00e9zal I, Martini E, Chiang SC, Marquardt N, et al. CD49a expression defines tissue-resident CD8(+) T cells poised for cytotoxic function in human skin. Immunity 2017; 46: 287-300.","DOI":"10.1016\/j.immuni.2017.01.009"},{"key":"4091","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.immuni.2017.01.009","DOI":"10.1016\/j.immuni.2017.01.009"},{"key":"4092","doi-asserted-by":"crossref","unstructured":"Kanda N, Koto M, Hoashi T, Saeki H. Case of alopecia areata during dupilumab treatment for atopic dermatitis. J Dermatol 2019; 46: e332-e333.","DOI":"10.1111\/1346-8138.14880"},{"key":"4093","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/1346-8138.14880","DOI":"10.1111\/1346-8138.14880"},{"key":"4094","doi-asserted-by":"crossref","unstructured":"Maloney NJ, Worswick S, Cheng K. Development of alopecia in patients treated with dupilumab. Dermatol Ther 2019; 32: e12869.","DOI":"10.1111\/dth.12869"},{"key":"4095","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/dth.12869","DOI":"10.1111\/dth.12869"},{"key":"4096","doi-asserted-by":"crossref","unstructured":"St\u00e4nder S, Trense Y, Tha\u00e7i D, Ludwig RJ. Alopecia areata development in atopic dermatitis patients treated with dupilumab. J Eur Acad Dermatol Venereol 2020; 34: e612-e613.","DOI":"10.1111\/jdv.16493"},{"key":"4097","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.16493","DOI":"10.1111\/jdv.16493"},{"key":"4098","doi-asserted-by":"crossref","unstructured":"Ito T, Kageyama R, Nakazawa S, Honda T. Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata. Exp Dermatol 2020; 29: 726-732.","DOI":"10.1111\/exd.14129"},{"key":"4099","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/exd.14129","DOI":"10.1111\/exd.14129"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/545\/548","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/545\/549","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/545\/548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T09:20:42Z","timestamp":1675761642000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,7]]}},"URL":"https:\/\/doi.org\/10.2340\/actadv.v101.545","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,28]]}}}